Beryllium carbonate (CHEM000570)

IdentificationTaxonomyBiological PropertiesPhysical PropertiesToxicity ProfileSpectraConcentrationsLinksReferencesTargets (3)XML
Record Information
Version1.0
Creation Date2009-03-21 00:50:01 UTC
Update Date2026-04-05 20:32:01 UTC
Accession NumberCHEM000570
Identification
Common NameBeryllium carbonate
ClassSmall Molecule
DescriptionBeryllium carbonate is a chemical compound with the chemical formula BeCO3. There are three forms reported, anhydrous, a tetrahydrate and basic beryllium carbonate. The anhydrous form is reported to be unstable, decomposing to BeO and carbon dioxide, and requiring storage under CO2. The tetrahydrate is said to be formed when CO2 is bubbled through a solution of Be(OH)2 and is also reported to be similarly unstable. Basic beryllium carbonate is a mixed salt, which can be prepared by the reaction of beryllium sulfate and ammonium carbonate, and contains both carbonate and hydroxide ions, with formula Be2CO3(OH)2.
Contaminant Sources
  • IARC Carcinogens Group 1
  • T3DB toxins
Contaminant Type
  • Beryllium Compound
  • Industrial/Workplace Toxin
  • Inorganic Compound
  • Organic Compound
  • Pollutant
  • Synthetic Compound
Chemical Structure
Thumb
MOLSDFPDBSMILESInChI
Synonyms
ValueSource
Beryllium carbonic acidGenerator
Chemical FormulaCH2BeO3
Average Molecular Mass71.036 g/mol
Monoisotopic Mass71.011 g/mol
CAS Registry Number13106-47-3
IUPAC Nameberyllium(2+) ion carbonic acid
Traditional Nameberyllium(2+) ion carbonic acid
SMILES[Be++].OC(O)=O
InChI IdentifierInChI=1S/CH2O3.Be/c2-1(3)4;/h(H2,2,3,4);/q;+2
InChI KeyZBUQRSWEONVBES-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as organic carbonic acids. Organic carbonic acids are compounds comprising the carbonic acid functional group.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassOrganic carbonic acids and derivatives
Sub ClassOrganic carbonic acids
Direct ParentOrganic carbonic acids
Alternative Parents
Substituents
  • Carbonic acid
  • Organic oxygen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Carbonyl group
  • Organic cation
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External DescriptorsNot Available
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cytoplasm
  • Extracellular
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateSolid
AppearanceWhite powder (4).
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility231 g/LALOGPS
logP0.6ALOGPS
logP0.25ChemAxon
logS0.57ALOGPS
pKa (Strongest Acidic)6.05ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area57.53 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity9.5 m³·mol⁻¹ChemAxon
Polarizability4.23 ųChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
SpectraNot Available
Toxicity Profile
Route of ExposureInhalation (3)
Mechanism of ToxicityOnce in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. This MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. The resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmonary) granulomas. Beryllium's toxicity may be controlled by the iron-storage protein ferritin, which sequesters beryllium by binding it and preventing it from interacting with other enzymes. (4, 1, 2)
MetabolismBeryllium is absorbed mainly through the lungs, where it enters the bloodstream and is transported throughout the body by binding to prealbumins and gamma-globulins. Beryllium accumulates in lung tissue and the skeleton. It is excreted mainly in the urine. (4)
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)1, carcinogenic to humans. (6)
Uses/SourcesBeryllium carbonate is used in processing ores and in chemical and nuclear applications (7).
Minimum Risk LevelChronic Oral: 0.002 mg/kg/day (5)
Health EffectsAcute inhalation of a high level of beryllium can result in a pneumonia-like condition called acute beryllium disease. Chronic inhalation of beryllium can cause an inflammatory reaction in the respiratory system called chronic beryllium disease. Chronic beryllium disease may result in anorexia and weight loss, as well as right side heart enlargement and heart disease in advanced cases. Chronic exposure can also increase the risk of lung cancer. Skin contact with beryllium results in contact dermatitus. (3, 4)
SymptomsChronic beryllium disease causes fatigue, weakness, difficulty breathing, and a persistent dry cough. (3, 4)
TreatmentChronic beryllium disease is treated with immunosuppressive medicines, usually of the glucocorticoid class. (3)
Concentrations
Not Available
DrugBank IDNot Available
HMDB IDNot Available
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkBeryllium carbonate
Chemspider IDNot Available
ChEBI IDNot Available
PubChem Compound ID54606123
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available